Cover Image
市場調查報告書

製藥業的產業預測與採購分析

Pharmaceutical Industry Business Outlook and Procurement Report H1 2016

出版商 Kable 商品編碼 356895
出版日期 內容資訊 英文 44 Pages
訂單完成後即時交付
價格
Back to Top
製藥業的產業預測與採購分析 Pharmaceutical Industry Business Outlook and Procurement Report H1 2016
出版日期: 2016年04月29日 內容資訊: 英文 44 Pages
簡介

本報告提供製藥業的產業預測與採購活動調查分析,主要的商務上的優先事項,新興、先進國家市場,M&A活動的變化,商務上的顧慮事項,設備投資的變化,購買的偏好,預算分配,設備、醫藥品類別相關的系統性資訊。

簡介

全球產業預測:2016年前半期

  • 策略性的商務上的優先事項
  • 有大幅成長可能性的新興市場
  • 先進國家市場的成長可能性
  • M&A
  • 主要的商務課題
  • 設備投資的預測

採購預算,支出預測,高收穫率類別

  • 製藥設備的購買偏好
  • 每次購買的平均支出
  • 設備投資、營運成本間的採購預算的分佈
  • 採購預算支出的變化
  • 製藥設備預算的變動
  • 製藥設備市場上量收益能預計的地區
  • 主要的醫藥品類別
  • 最多的醫藥品設備類型

附錄

圖表

目錄
Product Code: KG6230PR

Summary

The key priorities forecast in the business structure for global pharmaceutical industry executives in H1 2016 (April-September 2016) are new product development and improving operational efficiency. China, India, and Brazil are the leading emerging markets that are expected to offer the most opportunities for global pharmaceutical industry growth in H1 2016. Market uncertainty and rising competition are the immediate business concerns for global pharmaceutical industry executives. The gradual slowdown and restructuring of economic activity in China and tightening of the monetary policy in the US are creating a major concern for the pharmaceutical industry. Packaging equipment is expected to offer significant growth opportunities within the pharmaceutical industry in Asia-Pacific. Avoidance of counterfeiting and provision of longer shelf life are identified as the key drivers for pharmaceutical packaging companies to witness significant business opportunities within the Asia-Pacific region.

Key Findings

  • The top three key priorities for H1 2016 (April-September 2016) as identified by respondents include new product development, improving operational efficiency, and expansion in current market
  • Developed markets such as the US, the UK, and Japan are identified as important regions for growth over the next six months by pharmaceutical respondents
  • New product development and IT infrastructure development will record a significant increase or notable increase in capital expenditure over the next six months
  • Overall, 52% of executives operating in Europe assigned high preference for outright purchase of pharmaceutical equipment
  • In Asia-Pacific, executives forecast packaging equipment and process equipment will offer significant revenue growth opportunities within the pharmaceutical industry

Synopsis

Kable's Pharmaceutical Industry Business Outlook and Procurement Report H1 2016 examines executives' opinion on business outlook and procurement activities over April-September 2016. It also highlights key business priorities, supplier price variations, changes in capital expenditure, and the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry. Additionally, it provides information categorized by region and company type.

What else does this report offer?

  • Key business priorities: examines the pharmaceutical companies' important priorities for H1 (April-September) 2016
  • Emerging and developed markets: provides information about key emerging and developed markets, which will offer most growth over H1 2016
  • Change in MandA activity: analyzes pharmaceutical industry executives' opinion on changes in merger and acquisition activity globally
  • Business concerns: identifies major business concerns that are likely to impact pharmaceutical companies
  • Change in capital expenditure: tracks the expected change in capital expenditure both globally and regionally
  • Purchase preferences: analyzing the purchasing behavior towards pharmaceutical equipment and investment allocations in the pharmaceutical equipment categories
  • Budget allocation: examining total procurement budget split between capital expenditure and operating expenditure, and tracking the changes in the budget for 2016 and expectations for 2017
  • Equipment and drug categories: highlights the key equipment and drug categories with the highest revenue contribution to the pharmaceutical industry from 2016-2020

Reasons To Buy

  • Highlights key business priorities thus helping pharmaceutical companies to realign business strategy
  • Develop or adjust business expansion plans by using significant growth opportunities offered by key emerging and developed markets
  • Make changes in procurement budget allocations through procurement budget projections anticipated by executives for April-September 2016
  • Helps to alter investment allocation by understanding key focus areas highlighted by survey respondents during H1 2016
  • Enables organizations to make key decisions on purchase preferences and investments in pharmaceutical equipment

Table of Contents

Introduction

  • Definitions
  • Methodology and sample size
  • Respondent profile

Global Business Outlook in H1 2016

  • Strategic business priorities
  • Emerging markets with significant growth potential
  • Growth potential for developed markets
  • Mergers and acquisition
  • Leading business concerns
  • Capital expenditure projections

Procurement Budget, Expenditure Outlook, and High-yield Categories

  • Purchase preferences for pharmaceutical equipment
  • Average expenditure per purchase
  • Distribution of procurement budget between capital and operating expenditure
  • Change in procurement budget expenditure
  • Variation in pharmaceutical equipment budget from 2015-2016 to 2016-2017
  • Highest revenue contributing regions for pharmaceutical equipment's market, 2016-2020
  • Leading drug categories, 2016-2020
  • Top most pharmaceutical equipment types, 2016-2020

Appendix

List of Figures

  • Figure 1: Organizations' Top Priorities - Overall, Apr 2016-Sep 2016
  • Figure 2: Organizations' Top Priorities - By Region, Apr 2016-Sep 2016
  • Figure 3: Organizations' Top Priorities - By Company Types, Apr 2016-Sep 2016
  • Figure 4: Emerging Market with Significant Growth Opportunities - Overall, Apr 2016-Sep 2016
  • Figure 5: Top Five Emerging Market with Significant Growth Opportunities - By Region, Apr 2016-Sep 2016
  • Figure 6: Top Five Emerging Market with Significant Growth Opportunities - By Company Types, Apr 2016-Sep 2016
  • Figure 7: Developing Markets with Prominent Growth Prospects - Overall, Apr 2016-Sep 2016
  • Figure 8: Top Five Developing Markets with Prominent Growth Prospects - By Region, Apr 2016-Sep 2016
  • Figure 9: Top Five Developing Markets with Prominent Growth Prospects - By Company Types, Apr 2016-Sep 2016
  • Figure 10: Change in Mergers and Acquisitions, Overall and Regional, Apr 2016-Sep 2016
  • Figure 11: Change in Mergers and Acquisitions, By Company Types, Apr 2016-Sep 2016
  • Figure 12: Major Concerns for Organizations - Overall, Apr 2016-Sep 2016
  • Figure 13: Major Concerns for Organizations - By Region, Apr 2016-Sep 2016
  • Figure 14: Major Concerns for Organizations - By Company Types, Apr 2016-Sep 2016
  • Figure 15: Change in Capital Expenditure in Key Areas - Overall, Apr 2016-Sep 2016
  • Figure 16: Change in Capital Expenditure in Key Areas - By Region, Apr 2016-Sep 2016
  • Figure 17: Change in Capital Expenditure in Key Areas - By Company Types, Apr 2016-Sep 2016
  • Figure 18: Purchase Preferences - By Region
  • Figure 19: Average Expenditure Per Purchase - Overall
  • Figure 20: Distribution of Procurement Budget - By Region
  • Figure 21: Change in Procurement Budget Expenditure - By Region
  • Figure 22: Change in Pharmaceutical Equipment Budget - By Region
  • Figure 23: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2016 - Overall
  • Figure 24: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2020 - Overall
  • Figure 25: Highest Revenue Contributing Regions for Pharmaceutical Equipment's Market, 2016-2020 - By Company Types
  • Figure 26: Leading Drug Categories By Region, 2016 - A - Overall
  • Figure 27: Leading Drug Categories By Region, 2016 - B - Overall
  • Figure 28: Leading Drug Categories By Region, 2020 - A - Overall
  • Figure 29: Leading Drug Categories By Region, 2020 - B - Overall
  • Figure 30: Top Most Pharmaceutical Equipment Types By Region, 2016 - A - Overall
  • Figure 31: Top Most Pharmaceutical Equipment Types By Region, 2016 - B - Overall
  • Figure 32: Top Most Pharmaceutical Equipment Types By Region, 2020 - A - Overall
  • Figure 33: Top Most Pharmaceutical Equipment Types By Region, 2020 - B - Overall
Back to Top